Giuseppe Luigi Banna

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Marina Chiara Garassino, Jennifer G. Whisenant, Li‐Ching Huang et al. · The Lancet Oncology · 2020 · 624 citations · Full text

Medicine, Oncology, Clinical Epidemiology +3

Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme

Roberto Pallini, Lucia Ricci‐Vitiani, Giuseppe Luigi Banna et al. · Clinical Cancer Research · 2008 · 363 citations

Medicine, Cell Biology, Oncology +17

First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status

Francesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri et al. · European Journal of Cancer · 2020 · 147 citations · Full text

Medicine, Oncology, Pharmacology +13

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

Alessio Cortellini, Massimo Di Maïo, Olga Nigro et al. · Journal for ImmunoTherapy of Cancer · 2021 · 144 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract

Cora N. Sternberg, Yohann Loriot, Nicholas D. James et al. · European Urology · 2019 · 134 citations · Full text

Medicine, Oncology, Pharmacotherapy +14